NO905511D0 - Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon. - Google Patents
Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon.Info
- Publication number
- NO905511D0 NO905511D0 NO905511A NO905511A NO905511D0 NO 905511 D0 NO905511 D0 NO 905511D0 NO 905511 A NO905511 A NO 905511A NO 905511 A NO905511 A NO 905511A NO 905511 D0 NO905511 D0 NO 905511D0
- Authority
- NO
- Norway
- Prior art keywords
- metanesulphonamido
- etanon
- fluorphenyl
- acetamidophenyl
- piperidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45449789A | 1989-12-21 | 1989-12-21 | |
US60465190A | 1990-11-01 | 1990-11-01 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO905511D0 true NO905511D0 (no) | 1990-12-20 |
NO905511L NO905511L (no) | 1991-06-24 |
NO176565B NO176565B (no) | 1995-01-16 |
NO176565C NO176565C (no) | 1995-04-26 |
Family
ID=27037488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO905511A NO176565C (no) | 1989-12-21 | 1990-12-20 | Analogifremgangsmåte for fremstilling av antitrombotisk aktive forbindelser |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0437790B1 (no) |
JP (1) | JP2934323B2 (no) |
KR (1) | KR0184641B1 (no) |
CN (1) | CN1025853C (no) |
AR (1) | AR247200A1 (no) |
AT (1) | ATE133163T1 (no) |
AU (1) | AU635098B2 (no) |
CA (1) | CA2032797C (no) |
DE (1) | DE69024933T2 (no) |
DK (1) | DK0437790T3 (no) |
ES (1) | ES2084642T3 (no) |
FI (1) | FI96946C (no) |
GR (1) | GR3018895T3 (no) |
HU (1) | HU210590B (no) |
IE (1) | IE71039B1 (no) |
IL (1) | IL96731A (no) |
NO (1) | NO176565C (no) |
NZ (1) | NZ236501A (no) |
PT (1) | PT96291B (no) |
TW (1) | TW199145B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292752A (en) * | 1989-12-21 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Antithrombotic compounds |
HU214587B (hu) * | 1990-06-07 | 1998-04-28 | Merrell Dow Pharmaceuticals Inc. | Eljárás 1-piperidinil-alkanoil-aril-szulfonamid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények előállítására |
US5478846A (en) * | 1990-06-07 | 1995-12-26 | Merrell Dow Pharmaceuticals Inc. | 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia |
EP0661266A1 (en) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
PH23283A (en) * | 1986-02-26 | 1989-06-30 | Eisai Co Ltd | Piperidine derivative, pharmaceutical composition containing the same and method of use thereof |
AU609385B2 (en) * | 1987-01-12 | 1991-05-02 | Dominic A. Ricchio | Method and apparatus for improved water therapy |
US5093341A (en) * | 1987-12-17 | 1992-03-03 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine derivatives useful as antithrombolytic agents |
US5064838A (en) * | 1988-01-21 | 1991-11-12 | Merrell Dow Pharmaceuticals | 1,4-disubstituted-piperidinyl compounds as pain relievers |
JP2969359B2 (ja) * | 1989-01-13 | 1999-11-02 | 武田薬品工業株式会社 | 環状アミン化合物 |
-
1990
- 1990-12-17 NZ NZ236501A patent/NZ236501A/en unknown
- 1990-12-18 TW TW079110633A patent/TW199145B/zh active
- 1990-12-18 FI FI906246A patent/FI96946C/fi not_active IP Right Cessation
- 1990-12-18 AU AU68181/90A patent/AU635098B2/en not_active Ceased
- 1990-12-19 JP JP2411705A patent/JP2934323B2/ja not_active Expired - Fee Related
- 1990-12-19 IL IL9673190A patent/IL96731A/en not_active IP Right Cessation
- 1990-12-20 CA CA002032797A patent/CA2032797C/en not_active Expired - Fee Related
- 1990-12-20 PT PT96291A patent/PT96291B/pt not_active IP Right Cessation
- 1990-12-20 CN CN90110137.0A patent/CN1025853C/zh not_active Expired - Fee Related
- 1990-12-20 DE DE69024933T patent/DE69024933T2/de not_active Expired - Fee Related
- 1990-12-20 DK DK90124973.0T patent/DK0437790T3/da active
- 1990-12-20 HU HU908370A patent/HU210590B/hu not_active IP Right Cessation
- 1990-12-20 NO NO905511A patent/NO176565C/no not_active IP Right Cessation
- 1990-12-20 EP EP90124973A patent/EP0437790B1/en not_active Expired - Lifetime
- 1990-12-20 AT AT90124973T patent/ATE133163T1/de not_active IP Right Cessation
- 1990-12-20 KR KR1019900021184A patent/KR0184641B1/ko not_active IP Right Cessation
- 1990-12-20 ES ES90124973T patent/ES2084642T3/es not_active Expired - Lifetime
- 1990-12-20 AR AR90318688A patent/AR247200A1/es active
- 1990-12-20 IE IE463290A patent/IE71039B1/en not_active IP Right Cessation
-
1996
- 1996-02-01 GR GR960400292T patent/GR3018895T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK73193D0 (da) | Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner | |
NO180484C (no) | Fremgangsmåte for fremstilling av substituerte piperidiner | |
NO894086D0 (no) | Fremgangsmaate for fremstilling av piperidinylbenzimidazoler. | |
MX9102861A (es) | Nuevas 4-(4-imidazolil) piperidinas substituidas y procedimiento para su preparacion. | |
AU6720087A (en) | 4-(2-thiazolyl- and 4-(2-thiazolylamino-phenyl)-1,4- dihydropyridine derivatives | |
NO894786L (no) | Fremgangsmaate for fremstilling av propenonoksimetere. | |
NO900934L (no) | Fremgangsmaate for fremstilling av nye derivater av 4-substituerte piperaziner. | |
NL950021I2 (nl) | 2-(Difluormethoxy)-1,1,1,2-tretrafluorethaan als anestheticum. | |
NO885607D0 (no) | Fremgangsmaate for fremstilling av piperidinylforbindelser. | |
NO902776L (no) | Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer. | |
ATE288918T1 (de) | 1-(4-(1-(4-fluorphenyl)-1h-indol-3-yl)1-butyl)- spiro-(isobenzofuran-1(3h),4'-piperidin)- hydrohalogenide | |
NL7804388A (nl) | Nieuwe n-/1-(3-benzoylpropyl)-4-piperidyl/ sulfonzuur- amiden en werkwijze voor de bereiding daarvan. | |
NO155137C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon. | |
NO901832D0 (no) | Fremgangsmaate for fremstilling av polyketon. | |
NO905511D0 (no) | Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon. | |
FI914906A (fi) | 1-(3,4-dihydro-2-oxo-1h-kinolin-6-yl) -2-(4-(2-fenyletyl) piperidin-1-yl)etanol och -etanon, deras framstaellning och anvaendning inom terapi. | |
NO159532C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 1-(4-kinolyl)-2-(4-piperidyl)-etanol eller1-(4-kinolyl)-3-(4-piperidyl)-propanol. | |
NO883339D0 (no) | Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser. | |
DE3875543T2 (de) | 1-(2-(phenylmethyl)phenyl)-piperazin-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
NO880337L (no) | Fremgangsmaate for fremstilling av 3-aryl-5-alkylthio-4h-1,2,4-triazoler. | |
NO870891D0 (no) | Fremgangsmaate for fremstilling av 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonyl-derivater. | |
IT8423808A0 (it) | Procedimento per preparare 4-(2-fenossietil)-1,2,4-triazolone. | |
NO904034L (no) | Fremgangsmaate for fremstilling av 1-etylfenoksatiin-10,10-dioksyd. | |
NO882861D0 (no) | Fremgangsmaate for fremstilling av krystallinsk 2-(1-pentyl-3-guanidino) 4-(2-metyl-4-imidazolyl)-tiazol-dihydroklorid-trihydrat. | |
DE59002266D1 (de) | Verwendung von 4-(hydroxydi-phenylmethyl)-1-piperidyl-phenylalkan-derivaten zur herstellung eines antihistaminikums. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JUNE 2001 |